









Märkte
/
Aktien
/
nasdaq-qtrx
/

Quanterix Corp

QTRX

4.990USD

-0.180-3.48%

Handelsschluss 11/06, 16:00（ET）Kurse um 15 Minuten verzögert

193.98MMarktkapitalisierung

VerlustKGV TTM



Quanterix Corp

4.990

-0.180-3.48%

Übersicht Unternehmen Finanzen Analyse

Übersicht

Unternehmen

Finanzen

Analyse

mehr Informationen über Quanterix Corp Unternehmen

Quanterix Corporation is a life sciences company. The Company is engaged in developing ultra-sensitive digital immunoassay platforms that advance precision health for life sciences research and diagnostics. Its platforms are based on its digital Simoa detection technology. Its Simoa bead-based and planar array platforms enable customers to detect protein biomarkers in low concentrations in blood, serum, and other fluids. The Company's Simoa technology is based on traditional enzyme-linked immunosorbent assay (ELISA) technology. Its products include HD-X, SR-X, SP-X, Simoa assays and consumables, and NfL antibodies and NfL ELISA kits. It also offers contract research services for customers through its Accelerator Laboratory, which provides customers with access to Simoa technology and supports multiple projects and services, including sample testing, homebrew assay development and custom assay development. It has completed over 2,200 projects for 480 customers using its Simoa platforms.

Quanterix Corp Informationen



BörsenkürzelQTRX

Name des UnternehmensQuanterix Corp

IPO-datumDec 07, 2017

CEODr. Masoud Toloue, Ph.D.

Anzahl der mitarbeiter471

WertpapierartOrdinary Share

GeschäftsjahresendeDec 07

Addresse900 Middlesex Turnpike

StadtBILLERICA

BörseNASDAQ Global Market Consolidated

LandUnited States of America

Postleitzahl01821

Telefon16173019400

Websitehttps://www.quanterix.com/

BörsenkürzelQTRX

IPO-datumDec 07, 2017

CEODr. Masoud Toloue, Ph.D.

Führungskräfte von Quanterix Corp



Name

Name/Position

Position

Aktienbesitz

Veränderung

Dr. David R. Walt, Ph.D.

Independent Director

1.86M

+0.14%

Dr. Masoud Toloue, Ph.D.

President, Chief Executive Officer, Director

287.11K

-0.52%

Mr. William P. (Bill) Donnelly

Independent Chairman of the Board

138.14K

+3.81%

Ms. Karen A. Flynn

Independent Director

26.41K

Ms. Vandana Sriram, CPA

Chief Financial Officer, Treasurer

15.07K

-1.50%

Mr. Scott Mendel

Director

6.27K

+49.75%

Dr. Myla P. Lai-Goldman, M.D.

Director

5.02K

+70.88%

Mr. Jeffrey Thomas (Jeff) Elliott

Independent Director

3.96K

-79.63%

Dr. Ivana Magov Evi-liebisch, J.D., Ph.D.

Independent Director

Mr. Paul M. Meister

Independent Director

Name

Name/Position

Position

Aktienbesitz

Veränderung

Dr. David R. Walt, Ph.D.

Independent Director

1.86M

+0.14%

Dr. Masoud Toloue, Ph.D.

President, Chief Executive Officer, Director

287.11K

-0.52%

Mr. William P. (Bill) Donnelly

Independent Chairman of the Board

138.14K

+3.81%

Ms. Karen A. Flynn

Independent Director

26.41K

Ms. Vandana Sriram, CPA

Chief Financial Officer, Treasurer

15.07K

-1.50%

Mr. Scott Mendel

Director

6.27K

+49.75%

Umsatzaufteilung

Währung: USDAktualisiert: Mon, Oct 6

FY2025Q2

FY2025Q1

FY2024

FY2024Q2

FY2024Q1

FY2023

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Product revenue

16.83M

68.83%

Service and other revenue

7.09M

28.99%

Collaboration and license revenue

532.00K

2.18%

Nach RegionUSD

Name

Umsatz

Anteil

North America

14.67M

60.01%

EMEA

6.51M

26.61%

Asia Pacific

3.27M

13.38%

Nach Geschäftsbereich

Nach Region

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Product revenue

16.83M

68.83%

Service and other revenue

7.09M

28.99%

Collaboration and license revenue

532.00K

2.18%

Aktionärsstatistik

Aktualisiert: Sat, Nov 1

Aktionäre

Aktionärstypen

Aktionäre

Anteil

Portolan Capital Management, L.L.C.

7.82%

Columbia Threadneedle Investments (UK)

6.73%

BlackRock Institutional Trust Company, N.A.

5.70%

The Vanguard Group, Inc.

5.44%

Kent Lake PR LLC

4.50%

Andere

69.81%

Aktionäre

Anteil

Portolan Capital Management, L.L.C.

7.82%

Columbia Threadneedle Investments (UK)

6.73%

BlackRock Institutional Trust Company, N.A.

5.70%

The Vanguard Group, Inc.

5.44%

Kent Lake PR LLC

4.50%

Andere

69.81%

Aktionärstypen

Aktionäre

Anteil

Investment Advisor/Hedge Fund

34.76%

Investment Advisor

19.39%

Hedge Fund

13.18%

Individual Investor

5.88%

Research Firm

3.94%

Pension Fund

0.67%

Bank and Trust

0.27%

Family Office

0.13%

Venture Capital

0.12%

Andere

21.65%

Institutionelle Beteiligung



Aktualisiert: Wed, Oct 1

Berichtszeitraum

Anzahl der Institutionen

Gehaltenen Aktien

Anteil

Veränderung

2025Q3

383

33.64M

72.39%

-10.02M

2025Q2

391

36.46M

81.18%

-12.95M

2025Q1

401

40.45M

104.19%

-6.42M

2024Q4

388

38.02M

98.63%

-6.28M

2024Q3

386

36.47M

95.03%

-5.94M

2024Q2

394

35.66M

93.20%

-9.57M

2024Q1

395

35.56M

93.43%

-9.17M

2023Q4

388

34.77M

91.99%

-10.35M

2023Q3

382

36.53M

97.35%

-9.84M

2023Q2

388

36.74M

98.24%

-9.95M

Aktionärsaktivitäten



Name

Gehaltenen Aktien

Anteil

Veränderung

Änderung%

Datum

Portolan Capital Management, L.L.C.

3.63M

7.82%

+670.23K

+22.62%

Jun 30, 2025

Columbia Threadneedle Investments (UK)

3.13M

6.73%

+128.33K

+4.28%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

2.65M

5.7%

-36.11K

-1.35%

Jun 30, 2025

The Vanguard Group, Inc.

2.53M

5.44%

+3.27K

+0.13%

Jun 30, 2025

Kent Lake PR LLC

2.09M

4.5%

-211.50K

-9.19%

Jul 14, 2025

Walt (David R)

1.86M

4.01%

+2.15K

+0.12%

Jul 31, 2025

Invenomic Capital Management LP

1.14M

2.46%

+242.86K

+26.92%

Jun 30, 2025

William Blair Investment Management, LLC

1.13M

2.43%

+21.92K

+1.98%

Jun 30, 2025

Columbia Threadneedle Investments (US)

1.11M

2.39%

+393.31K

+54.91%

Jun 30, 2025

Easterly Investment Partners LLC

1.08M

2.33%

-241.99K

-18.25%

Jun 30, 2025

Verbundene ETFs



Aktualisiert: Thu, Nov 6

Name

Anteil

Invesco NASDAQ Future Gen 200 ETF

0.58%

iShares Micro-Cap ETF

0.04%

Fidelity Enhanced Small Cap ETF

0.03%

Avantis US Small Cap Equity ETF

0.02%

Invesco RAFI US 1500 Small-Mid ETF

0.02%

iShares Biotechnology ETF

0.02%

Proshares Ultra Russell 2000

0.01%

ProShares UltraPro Russell2000

0.01%

iShares Russell 2000 Value ETF

0.01%

Global X Russell 2000 ETF

0.01%

Invesco NASDAQ Future Gen 200 ETF

Anteil0.58%

iShares Micro-Cap ETF

Anteil0.04%

Fidelity Enhanced Small Cap ETF

Anteil0.03%

Avantis US Small Cap Equity ETF

Anteil0.02%

Invesco RAFI US 1500 Small-Mid ETF

Anteil0.02%

iShares Biotechnology ETF

Anteil0.02%

Proshares Ultra Russell 2000

Anteil0.01%

ProShares UltraPro Russell2000

Anteil0.01%

iShares Russell 2000 Value ETF

Anteil0.01%

Global X Russell 2000 ETF

Anteil0.01%

Dividende



In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.

Datum

Dividende

Stichtag für die Aktienregistrierung

Zahltag

Ex-Dividendentag

Keine Daten

Aktien-Split



Datum

Art

Verhältnis

Keine Daten

Datum

Art

Verhältnis

Keine Daten

KeyAI

